OSI Pharma to consolidate U.S. workers

After running into resistance against its plans to expand in the Broadhollow Bioscience Park on Long Island, OSI Pharmaceuticals says it has decided to consolidate 350 employees in lower Westchester County. The move out of Long Island is a blow for economic development officials there who had been attempting to make the area a mecca for biotech companies. OSI is paying $27 million to acquire a 43-acre site with 400,000 square feet of office and lab space. Report

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.